Keywords
Unified Health System
Public Expenditures
Brazil
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the impact of the number of individuals with chromosomal abnormalities on public spending in the Brazilian Unified Health System (SUS) in its macro-regions between 2008 and 2024. Methods: The study adopted a quantitative, ecological-observational, retrospective, and analytical approach, with data extracted from the TABNET website. Results: It was observed that the region with the highest expenditure in the stipulated period was the Southeast, with an annual average of R$34,255.88 among all patients with chromosomal abnormalities, almost half the Brazilian average for the same period, which was R$75,840. In descending order of values, the Northeast, South, Central-West, and North regions had averages of R$18,577.25, R$13,144.96, R$5,613.16, and R$5,208.98, respectively. This study corroborates other Brazilian studies on the subject. The differences observed between regions can be explained by several structural and healthcare factors. The heterogeneous coverage of epidemiological surveillance systems and regional inequalities may influence the underestimation of healthcare demands. Conclusion: It is possible to affirm that the costs associated with patients with chromosomal abnormalities have a significant impact on public health expenditures within the Brazilian Unified Health System (SUS).
References
ACERO-GARCÉS DO, et al. Fragile X syndrome in children. Colombia Médica, 2023; 54(2): e4005089.
ALFARO HGDC, et al. Analysis of Down syndrome newborn outcomes in three neonatal intensive care units in Rio de Janeiro, Brazil. Revista da Associação Médica Brasileira, 2024; 70(3): e20231186.
ANTONARAKIS SE, et al. Down syndrome. Nature Reviews Disease Primers, 2020; 6(1): 9.
BERGLUND A, et al. The epidemiology of sex chromosome abnormalities. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2020; 184(2): 202–215.
BERMUDEZ BEBV, et al. Quality of life in Down syndrome in Brazil: a cross-sectional study. Arquivos de Neuro-Psiquiatria, 2023; 81(11): 943–948.
BLANCO-MONTAÑO A, et al. Risk factors in the origin of Down syndrome. Revista Médica del Instituto Mexicano del Seguro Social, 2023; 61(5): 638–644.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Análise da situação epidemiológica das anomalias congênitas no Brasil, 2010 a 2022. 2024. (Boletim Epidemiológico, 55: 6).
DA SILVA MARTINS FI, et al. Internação e mortalidade hospitalar com caráter de urgência no estado do Ceará: uma análise epidemiológica de 2008 a 2023. Amazônia: Science Health, 2024; 12(2): 120–133.
DUNN AC, et al. Adjusting health expenditures for inflation: a review of measures for health services research in the United States. Health Services Research, 2016; 53: 1.
FUNDAÇÃO GETULIO VARGAS. Índice Geral de Preços – Mercado (IGP-M): metodologia. Rio de Janeiro: FGV IBRE, 2024.
GRAVHOLT CH, et al. Turner syndrome: mechanisms and management. Nature Reviews Endocrinology, 2019; 15(10): 601–614.
JUNIOR EDCQ, et al. Perfil das internações hospitalares com caráter de urgência no estado de Alagoas entre 2015 e 2019. 2022.
KREPISCHI ACV, et al. Chromosomal microarray analyses from 5778 patients with neurodevelopmental disorders and congenital anomalies in Brazil. Scientific Reports, 2022; 12(1): 15184.
LEUTHNER SR e ACHARYA K. Perinatal counseling following a diagnosis of trisomy 13 or 18: incorporating the facts, parental values, and maintaining choices. Advances in Neonatal Care, 2020; 20(3): 204–215.
PIMENTEL PV e TAVARES GA. Análise do custo de internação relacionado a doenças crônicas não transmissíveis e suas principais complicações no Estado de Sergipe. 2023.
RIGGAN KA, et al. Evidence-based recommendations for delivering the diagnosis of X & Y chromosome multisomies in children, adolescents, and young adults: an integrative review. BMC Pediatrics, 2024; 24(1): 263.
SANTOS HLPC, et al. Public expenditure on hospitalizations for COVID-19 treatment in 2020, in Brazil. Revista de Saúde Pública, 2021; 55: 52.
SANTOS SSND e PORTILHO AJDS. Frequency of chromosomal syndromes in the Brazilian population between 2017 and 2021. Health Sciences Journal, 2022; 12: 75–82.
SILVEIRA MM, et al. Effect of COVID-19 on vaccination coverage in Brazil. Journal of Medical Microbiology, 2021; 70: 11.
WONGKRAJANG P, et al. Economic cost of patients with trisomy 13, 18, and 21 in a tertiary hospital in Thailand. PLoS One, 2023; 18(11): e0291918.